Jenni Tucker was a sophomore in college, studying to be a nurse, when the signs of her silent illness began to slowly appear. She felt tired all the time. She’d stay home all day, with no energy to get off the couch. The Southbridge, Mass. native was naturally pale, but she noticed her face lacked any color. Tucker, then 19, saw her doctor. And after a liver biopsy, she got a diagnosis that surprised her: she’d developed NASH, or nonalcoholic steatohepatitis, the most severe form of non...
What is NASH?Did you know that you can get liver disease even if you don’t drink alcohol? Nonalcoholic fatty liver disease (or NAFLD) is a condition in which fat builds up in the liver. NASH (or nonalcoholic steatohepatitis) is a type of NAFLD that can damage the liver. NASH occurs when the fat buildup in the liver leads to inflammation (hepatitis) and scarring. NASH can be life-threatening, as it can cause liver scarring (called cirrhosis) or liver cancer. It is estimated that 3% to 5% of the...
Living & Wellbeing
Non-alcoholic steatohepatitis (NASH) is a growing public health issue, affecting an estimated three to five percent of the global adult population.[i] It typically progresses slowly with few – if any – obvious or visible symptoms[ii],[iii], making it a largely unrecognized and underdiagnosed disease. Many physicians are not intimately familiar with NASH, and, for many patients, their diagnosis is the first time they’ve heard the term. NASH, by definition, is a serious, progressive form of non...
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.